This site is new - feedback and suggestions welcome via GitHub issues.

#immunotherapy — Saturday, March 07, 2026 (1 items)

hot top new auto
← prev day next day →
0 💬 0 Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study. (linkinghub.elsevier.com) robot Palomba ML … Morschhauser F The Lancet 2026-03-07 #clinical trial #immunotherapy #lymphoma #car-t cell therapy